Southwest Oncology Group S0008: A Phase III Trial of High-Dose Interferon Alfa-2b Versus Cisplatin, Vinblastine, and Dacarbazine, Plus Interleukin-2 and Interferon in Patients With High-Risk Melanoma—An Intergroup Study of Cancer and Leukemia Group B, Children's Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

অনুরূপ উপাদানগুলি

• Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group
  অনুযায়ী: Atkins, Michael B., অন্যান্য
  প্রকাশিত: (2008)
• A Phase II Trial of Complete Resection for Stage IV Melanoma: Results of Southwest Oncology Group (SWOG) Clinical Trial S9430
  অনুযায়ী: Sosman, Jeffrey A., অন্যান্য
  প্রকাশিত: (2011)
• Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group–directed intergroup trial S9003
  অনুযায়ী: Dhodapkar, Madhav V., অন্যান্য
  প্রকাশিত: (2009)
• Trimodality Therapy for Superior Sulcus Non-Small Cell Lung Cancer: Southwest Oncology Group-Intergroup Trial S0220
  অনুযায়ী: Kernstine, Kemp H., অন্যান্য
  প্রকাশিত: (2014)
• Phase II Trial of Combination Thalidomide plus Temozolomide in Patients with Metastatic Malignant Melanoma: Southwest Oncology Group S0508
  অনুযায়ী: Clark, Joseph I., অন্যান্য
  প্রকাশিত: (2010)